Journal of Bioanalysis & Biomedicine

4^th International Conference and Exhibition on Biologics & Biosimilars

October 26-28, 2015 Baltimore, USA

Keynote

• State of the biosimilar industry

  Patrick Lucy

  PDF HTML

• Evolving biosimilars regulatory landscape: US and EU

  Kamali Chance

  PDF HTML

• Emerging markets considerations for biosimilar development and registration

  Christopher J Leintz

  PDF HTML

• There’s a saying that “Expression systems aren’t everything, but everything is nothing without a good expression system”

  Mark A Emalfarb

  PDF HTML

• Succeeding in the biosimilars market: A pure play perspective

  Sarfaraz K Niazi

  PDF HTML

• Biologics and biosimilars: The current litigation landscape in Canada

  Angela Furlanetto

  PDF HTML